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Expression of human leukocyte elastase inhibitor, elafin, otherwise known as 
skin-derived antileukoproteinase inhibitor (SKALP), was investigated in nor­
mal and abnormal oral tissues using a specific anti-SKALP rabbit antiserum. 
Weak staining was observed in keratinizing epithelia of normal oral mucosa but 
not in non-keratinizing mucosa. Increased expression was also observed in the 
suprabasal layers of dysplastic oral epithelia and in well-differentiated 
squamous cell carcinoma, but not in basal cell carcinoma. A uniform strong 
expression was observed in all supra-basal layers of odontogenic keratocyst epithe­
lia, except in regions where inflammatory infiltrate was adjacent to keratocyst 
epithelia. In contrast, elafin expression in a small number of dentigerous cysts 
and ameloblastomas was more patchy. The increased levels of elafin in keratocyst 
epithelia and dysplastic tissue may be a cellular homoeostatic response to generate 
a protective barrier preventing proteolytic degradation of underlying elastic 
tissue.
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An understanding of mechanisms con­
trolling levels of proteolytic activity in 
normal and diseased tissues is being 
sought by many independent research 
groups in widely different fields because 
of their importance in processes such as 
morphogenesis, angiogenesis, tissue re­
pair and tumour invasion (1,2). Unbal­
anced human leukocyte elastase (HLE) 
proteolytic activity is widely recognised 
to play an important pathological role 
in a number of diseases including em­
physema, adult respiratory distress syn­
drome, psoriasis and the bullous der­
matoses (3, 4). B r ig g a m a n  et al (5) 
demonstrated that pro teases such as 
HLE, at physiological concentrations, 
could disrupt the epithelial-connective 
tissue junction of human skin without 
having adverse effects on epithelial or 
connective tissue matrices. HLE func­
tion is regulated by endogenous inhibi­
tors such as elafin, p2-macroglobulin, 
antileukoprotease and ai-antitrypsin. 
However, with the exception of elafin, 
all these pro tease inhibitors tend to be 
relatively non-specific in that they are
potent trypsin inhibitors as well as be­
ing active against serine elastases.
Elafin, alternatively known as skin- 
derived antileukoproteinase inhibitor 
(SKALP), is an epithelial-specific, cat­
ionic, elastase inhibitor, of molecular 
mass 6-kDa in free and 9.9-kDa in im­
mobilized forms (6), that has been iden­
tified in cultured kcratinoeytcs (7), the 
scales of psoriatic lesions and in bron­
chial secretions (8). It is expressed as 
preproclafin, which is then processed to 
the mature elafin molecule found in 
psoriatic lesions (9). Although an 
increased level of elafin expression is 
observed in psoriatic scales compared 
to normal epidermis, the level of HLE 
activity was reported to be thirty-one 
fold greater than that observed in nor­
mal skin (3). Hence, increased levels of 
elafin may be swamped by markedly 
increased levels of HLE.
The odontogenic keratocyst (10), un­
like all other dental cyst types, is pecu­
liar in demonstrating an aggressive, lo­
cally destructive growth pattern. 
Further, during routine histological
processing, separation of epithelium 
from underlying connective tissue is 
often observed. The action of proteases, 
produced from cells located either in 
epithelia or connective tissue, could un­
derlie this apparent weakness (11). The 
formation of multiple odontogenic ker- 
atocysts in oral tissue is a feature of the 
naevoid, basal-cell carcinoma syndrome 
(NBCCS) (12, 13). Normal levels of 
proteolytic activity (stromelysin-3) have 
been reported in fibroblasts derived 
from skin of NBCCS patients (14, 15).
We have previously reported a large 
increase in the concentration of elafin 
transcripts in odontogenic keratocytes 
compared to those observed in normal 
oral (palatal) mucosa (16). The num­
bers of samples available for RNA ex­
traction and study was, however, 
limited. We wished, therefore, to further 
analyse elafin protein in keratoeysts to 
confirm these earlier findings and to es­
tablish whether increased transcription­
al levels were matched by increased 
protein expression. We also wished to 
determine whether this increase was
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limited to keratocysts epithelia or in­
cluded other abnormal oral and peri­
oral tissues. In this study we describe 
the levels of expression of elafin in a 
range of archival biopsies of normal 
and diseased oral tissues, using anti- 
SKALP anti serum.
Material and methods
Tissue samples
10% formalin-fixed, paraffin-embed­
ded, normal and diseased oral biopsies 
were obtained from pathology labora­
tory files. Sections were cut at 5 jam. 
Specimens are listed in Table L
Immiinohisio chemistry 
The characterisation of the polyclonal 
anti-SKALP rabbit antiserum has been 
described previously (17). It was used 
throughout at a dilution of 1/500 in 50 
mM tris/HCl buffer, pH 7.6, containing 
0.15 M sodium chloride (TBS).
Sections were hydrated by passage 
through xylene and graded alcohols to 
water. Endogenous peroxidase activity 
was blocked by incubating hydrated 
sections in 1% hydrogen peroxide in 
methanol for 20 min at 20°C. Non-spe­
cific protein binding sites were then
blocked by incubation of sections in a 
solution of 20% (v/v) normal swine se­
rum in TBS for 15 min at 20°C. Parallel 
sections were then overlayered with 
anti-SKALP-specific rabbit antiserum 
or pre-immune serum in TBS and incu­
bated at 20°C for 1 h. A 20 min wash 
with TBS was followed by 1 h incuba­
tion at 20°C with swine anti-rabbit per­
oxidase conjugate (P217, Dako Ltd, 
Bucks, UK, diluted 1:25 in 5% normal 
swine serum, in TBS). Sections were 
then washed as above with TBS and de­
veloped with 3 mM 3,3'-diaminoben- 
zidine (D-5637 Sigma, Poole, UK) in 
TBS, containing 3% (v/v) hydrogen per­
oxide. They were then given a light 
Mayer’s haematoxylin counters tain, de­
hydrated and mounted.
Sections of odontogenic keratocyst 
were used as positive controls. Negative 
controls included the concurrent use of 
pre-immune rabbit serum on parallel 
sections. In addition, sections from 
which primary or secondary antibodies 
had been excluded were also processed.
In order to indicate relative staining 
intensities of sections, the staining of 
each section was assessed visually and 
scored on a non-parametric 4-point 
scale:-
negative 0
consistent but weak staining 1
consistent moderate staining 2
consistent heavy staining 3
The uniformity of staining throughout 
the suprabasal layers of sections was as­
sessed and expressed as (U) uniform, or 
(P) patchy Ratings are given as a com­
bination of both intensity and unifor­
mity.
Mucosa was assessed for atypical ep­
ithelial features and judged using histo­
logical criteria as described by Sm it h  &  
P in d b o r g  (18).
Results
Elafin expression in normal gingiva
No staining was observed in any nor­
mal non-keratinizing gingival epitheli­
um. There was some mild, patchy cyto­
plasmic staining of upper prickle cell 
layers in normal keratinizing mucosal 
epithelia, and in epithelia of cyclospor­
in-enlarged gingival and fibro-epithelia! 
polyps, that related to surface kératini­
sation. We have shown previously that 
normal adult skin does not stain for 
elafin (17).
Elafin expression in cysts
All examples of uninflamed odontogen­
ic keratocyst epithelia demonstrated 
strong, uniform cytoplasmic staining 
throughout all epithelial layers (Fig. 1, 
Table 1). At sites where chronic in­
flammatory infiltrates impinged on epi­
thelia, no staining was observed (Fig. 
1), whilst adjacent epithelium gave 
strong positive staining. No differences 
were noted between keratocysts of 
NBCCS (/î=10) or non-syndrome 
origin (n=10). No staining was ob­
served in normal tooth follicles or in 
the majority of dentigerous cyst epithe­
lia («=8/10). However, in two cases a 
mild, patchy staining pattern was ob­
served in suprabasal positions (Table 1). 
No clinical or histological differences 
were observed in these two cysts to ac­
count for this.
Elafin expression in dysplastic and 
neoplastic lesions
An increased expression of elafin was 
observed in mild and moderate epitheli­
al dysplastic lesions (Table 1). In severe 
dysplasia the epithelial staining, 
although strong, was not uniform 
(Table I). Staining was uniform in car- 
cinoma-in-situ (Table 1).
In general, there was increased elafin
Table 1. Expression o f ElaJin/SKALP in normal and diseased tissue. Sections of tissues were 
screened as described in Material and methods. Results are expressed as the numbers of cases 
investigated, comparative staining intensities observed and uniformity of expression through­
out suprabasal layers, expressed as U -  uniform or P -  patchy
Tissue Number Staining Uniformity
Normal gingival epithelium1 6 0/1 U
Normal tooth follicle 5 0 —
Cysts
Odontogenic keratocyst (NBCCS) 10 3 U
Keratocyst (non-NBCCS) 10 3 U
Dentigerous cyst2 10 0/1 p
Residual cyst 10 0 —
Radicular cyst 10 0 —
Dysplasias
Mild epithelial dysplasia 10 2/3 U
Moderate epithelial dysplasia 10 1/2 U
Severe epithelial dysplasia 10 2/3 p
Neoplasms
Carcinoma-in-situ 10 2 U
Well-differentiated SCC3 10 0/1 p
Poorly-differentiated SCC 10 0/1 p
Basal cell carcinoma4 10 0 —
Ameloblastoma5 5 0 —
Other epithelia
Cyclosporin-enlarged gingiva 5 1 p
Fibro-epithelial polyp 5 0/1 p
Notes.
1 Grade 1 staining of prickle layer, only in keratinizing epithelia.
2 Staining only noted in 2 of 10 cases.
3 SCO -  Squamous cell carcinoma; staining was seen centrally in keratinized areas.
4 BCCs -  Basal cell carcinoma; staining was observed only in the granular layer of the surface 
epithelium directly over BCCs.
5 Ameloblastomas were only positive in the centre of acanthomatous (keratinizing) areas.
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Fig. J. Odon t ogen ic her a t o cys t * U n I n fl a in ed 
cyst lining (top left of picture): there is 
strong, even, perinuclear, cytoplasmic supra- 
basal epithelial staining with elafin. Centre 
picture (lower and upper right) shows kerato­
cyst epithelium associated with an inflam­
matory cell response (midnght.) and a loss of 
elafin reactivity, compared to unin flamed epi­
thelium (top left) (peroxidase label X.250 ap­
prox).
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/■'/if. 2, Squamous cell carcinoma. There is 
patchy light-to-moderate cytoplasmic stain­
ing centrally in the more differentiated is­
lands of carcinoma (top centre) in this overall 
well-differentiated SCC (peroxidase label 
X400 approx).
Fig, 3. Ameloblastoma. Patchy dense staining 
is evident centrally within some acantho- 
rnaious (keratinizing) islands of ameloblasto­
ma (lower centre) (peroxidase label X250 ap­
prox).
expression in neoplastic mucosal tissue 
compared to normal. There was uni­
form staining in the centre of well-dif­
ferentiated epithelial islands (Fig. 2), 
but this became less intense and patchy 
with increasing loss of differentiation. 
Positive staining was observed in epithe­
lia overlying BCC islands, whilst the is­
lands of BCC were negative.
No staining was observed in the 
majority of follicular and plexiform 
ameloblastomas; however, moderate, 
uniform, staining was observed central­
ly in islands of acanthomatous amel­
oblastomas (Fig. 3).
Discussion
An absence or weak expression of elafin 
was observed in epithelia of normal 
oral mucosa using a specific anti- 
SKALP rabbit antiserum. In contrast, 
a uniform expression was observed in 
all layers of keratocyst epithelia. These 
results indicate that increased levels of 
transcription of elafin in keratocyst epi­
thelia observed previously are also re­
flected by increased levels of elafin 
protein (10). At sites of inflammation 
beneath keratocyst epithelia, staining 
was lost. Loss of epitope could result 
from either an alteration in conforma­
tion due to binding or proteolytic de­
gradation of the elafin-protease com­
plex.
Most dentigerous cyst walls and all 
normal tooth follicles gave a negative 
staining pattern. However, a patchy ex­
pression pattern was observed in some 
(2/10), despite their similar histological 
appearance to negatively stained sec­
tions. The reasons for the different 
staining pattern in these sections is not 
known but may suggest a subtle differ­
ence in environmental factors regulat­
ing the growth and maintenance of ar­
chitecture of these cells. Similarly, light, 
positive staining was observed in the 
normal skin epithelia overlying BCC is­
lands, although its histological appear­
ance was no different from that of adja­
cent normal epithelia. This suggests 
that factors are being secreted from 
cells of the BCCs that are capable of 
diffusing to cause molecular changes in 
overlying epithelial cells, without overt 
alteration of their morphology. The na­
ture of these factors is not known. In- 
vitro, elafin expression was induced al­
ter injury in normal epidermis (2). 
Furthermore, these workers also ob­
served that the transcription of elafin is 
inducible in epithelial cells in-vitro. The 
expression was found to be dependent
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on the system used. Keratinocytes cul­
tured on a feeder layer of 3T3 fibro­
blasts (19) produce elafin. In contrast, 
those grown in keratinocyte growth me­
dium do not, unless supplemented with 
5% fetal calf sera (2). This induction 
was not due to the increased concentra­
tion of calcium in the media. Further 
evidence from experiments utilising ker­
atinocytes in suspension culture demon­
strated that the induction of elafin was 
not simply due to an induction of ter­
minal differentiation.
Increased levels of elafin expression 
were also observed in the suprabasal 
layers of dysplastic oral epithelia. SCC 
staining appeared to be related to tu­
mour differentiation. It was uniform in 
well-differentiated tumours but reduced 
and patchy in poorly-differentiated 
SCCs. The presence of increased levels 
of elafin in dysplastic tissue may serve 
to generate a barrier to protect tissue 
from proteolytic attack. N ara et al.
(20) have suggested that the repeating 
sequence located in the prosegment of 
elafin, which they named cementoin, 
could serve as a transglutaminase sub­
strate to anchor it to extracellular mat­
rix proteins, thereby protecting underly­
ing elastic tissues from proteolytic at­
tack,
We have previously reported in­
creased expression of a tumour-associ­
ated antigen (gp38) in epithelia of 
odontogenic keratocysts compared to 
other cyst types (21) and dysplastic epi­
thelia (22, 23). These expression pat­
terns are similar to those observed with 
the anti-SKALP antiserum. The use of 
these antibodies may assist not only for 
diagnostic purposes to distinguish be­
tween cyst types but also be useful in 
investigations into the development of 
these lesions.
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